| Literature DB >> 32445474 |
Abdoulie Bojang1, Sarah L Baines2, Bully Camara1, Romain Guerillot2, Liam Donovan2, Raquel Sánchez Marqués1, Ousman Secka1, Umberto D'Alessandro1, Christian Bottomley3, Benjamin P Howden2,4, Anna Roca1.
Abstract
In a post hoc analysis of samples from an intrapartum azithromycin randomized clinical trial, we found that children whose mothers had been treated with the drug had higher prevalence of macrolide-resistance genes msr(A) and ermC at 28 days but not at 12 months. The 2 genes were positively associated in the nasopharynx. CLINICAL TRIALS REGISTRATION: NCT1800942.Entities:
Keywords: zzm321990 ermC; zzm321990 msr(A)zzm321990 ; azithromycin; NPS; The Gambia
Year: 2020 PMID: 32445474 PMCID: PMC7819521 DOI: 10.1093/cid/ciaa609
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079